EP1192278A4 - 48 proteines secretees humaines - Google Patents

48 proteines secretees humaines

Info

Publication number
EP1192278A4
EP1192278A4 EP00937977A EP00937977A EP1192278A4 EP 1192278 A4 EP1192278 A4 EP 1192278A4 EP 00937977 A EP00937977 A EP 00937977A EP 00937977 A EP00937977 A EP 00937977A EP 1192278 A4 EP1192278 A4 EP 1192278A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00937977A
Other languages
German (de)
English (en)
Other versions
EP1192278A1 (fr
Inventor
Craig A Rosen
Steven M Ruben
George A Komatsoulis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1192278A1 publication Critical patent/EP1192278A1/fr
Publication of EP1192278A4 publication Critical patent/EP1192278A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
EP00937977A 1999-06-11 2000-06-01 48 proteines secretees humaines Withdrawn EP1192278A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13863199P 1999-06-11 1999-06-11
US138631P 1999-06-11
PCT/US2000/014963 WO2000077256A1 (fr) 1999-06-11 2000-06-01 48 proteines secretees humaines

Publications (2)

Publication Number Publication Date
EP1192278A1 EP1192278A1 (fr) 2002-04-03
EP1192278A4 true EP1192278A4 (fr) 2003-05-28

Family

ID=22482904

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00937977A Withdrawn EP1192278A4 (fr) 1999-06-11 2000-06-01 48 proteines secretees humaines

Country Status (5)

Country Link
EP (1) EP1192278A4 (fr)
JP (1) JP2003502058A (fr)
AU (1) AU5308200A (fr)
CA (1) CA2382185A1 (fr)
WO (1) WO2000077256A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541224B2 (en) 1996-03-14 2003-04-01 Human Genome Sciences, Inc. Tumor necrosis factor delta polypeptides
US7217788B2 (en) 1996-03-14 2007-05-15 Human Genome Sciences, Inc. Human tumor necrosis factor delta polypeptides
US6812327B1 (en) 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
US6689579B1 (en) 1996-10-25 2004-02-10 Human Genome Sciences, Inc. Polynucleotides encoding neutrokine-α
US20030095967A1 (en) 1999-01-25 2003-05-22 Mackay Fabienne BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
US7220840B2 (en) 2000-06-16 2007-05-22 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to B lymphocyte stimulator protein
ES2609016T3 (es) 2000-06-16 2017-04-18 Human Genome Sciences, Inc. Anticuerpos que se unen inmunoespecíficamente a BLyS
US20030091565A1 (en) 2000-08-18 2003-05-15 Beltzer James P. Binding polypeptides and methods based thereon
CA2441413A1 (fr) * 2001-03-27 2002-10-03 Human Genome Sciences, Inc. Proteines secretees humaines
JP2004537290A (ja) 2001-05-24 2004-12-16 ヒューマン　ジノーム　サイエンシーズ，　インコーポレイテッド 腫瘍壊死因子δ（ＡＰＲＩＬ）に対する抗体
EP1404807A4 (fr) * 2001-06-06 2005-03-23 Human Genome Sciences 20 proteines humaines secretees
WO2003087364A1 (fr) * 2002-04-16 2003-10-23 Tanabe Seiyaku Co., Ltd. Nouveau recepteur couple a la proteine g et son gene
WO2004071379A2 (fr) * 2003-02-17 2004-08-26 Bayer Healthcare Ag Methodes diagnostiques et therapeutiques relatives a des etats pathologiques lies au recepteur p2y10 couple a la proteine g
US9168286B2 (en) 2005-10-13 2015-10-27 Human Genome Sciences, Inc. Methods and compositions for use in treatment of patients with autoantibody positive disease
WO2007123765A2 (fr) 2006-03-31 2007-11-01 Human Genome Sciences Inc. NEUTROKINE-ALPHA et variant d'epissage de la neutrokine-alpha

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0665293A2 (fr) * 1994-01-26 1995-08-02 Hamamatsu Photonics K.K. Procédé de séquencage d'acides nucléiques
WO1998017783A1 (fr) * 1996-10-23 1998-04-30 Regents Of The University Of Michigan Vecteurs d'adenovirus perfectionnes
WO1998037184A1 (fr) * 1997-02-21 1998-08-27 The Regents Of The University Of California Genes de type 'cotyledon1 feuillu' et leurs utilisations
WO1998054963A2 (fr) * 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 proteines secretees humaines
WO1999018208A1 (fr) * 1997-10-02 1999-04-15 Human Genome Sciences, Inc. 101 proteines humaines secretees

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776746A (en) * 1996-05-01 1998-07-07 Genitope Corporation Gene amplification methods

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0665293A2 (fr) * 1994-01-26 1995-08-02 Hamamatsu Photonics K.K. Procédé de séquencage d'acides nucléiques
WO1998017783A1 (fr) * 1996-10-23 1998-04-30 Regents Of The University Of Michigan Vecteurs d'adenovirus perfectionnes
WO1998037184A1 (fr) * 1997-02-21 1998-08-27 The Regents Of The University Of California Genes de type 'cotyledon1 feuillu' et leurs utilisations
WO1998054963A2 (fr) * 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 proteines secretees humaines
WO1999018208A1 (fr) * 1997-10-02 1999-04-15 Human Genome Sciences, Inc. 101 proteines humaines secretees

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 15 March 2000 (2000-03-15), XP002221505, Database accession no. AC025596 *
DATABASE EMBL [online] 18 April 1997 (1997-04-18), XP002221504, Database accession no. AA340580 *
DATABASE EMBL [online] 9 April 1998 (1998-04-09), XP002221506, Database accession no. AL022395 *
DATABASE WPI Section Ch Week 199823, Derwent World Patents Index; Class B04, AN 1998-261485, XP002221508 *
DATABASE WPI Section Ch Week 199905, Derwent World Patents Index; Class B04, AN 1999-059865, XP002218276 *
DATABASE WPI Section Ch Week 199922, Derwent World Patents Index; Class B04, AN 1999-264022, XP002221507 *
See also references of WO0077256A1 *

Also Published As

Publication number Publication date
AU5308200A (en) 2001-01-02
CA2382185A1 (fr) 2000-12-21
JP2003502058A (ja) 2003-01-21
EP1192278A1 (fr) 2002-04-03
WO2000077256A1 (fr) 2000-12-21

Similar Documents

Publication Publication Date Title
EP1218408A4 (fr) 32 proteines humaines secretees
EP1212343A4 (fr) 52 proteines humaines secretees
EP1181390A4 (fr) 27 proteines humaines secretees
EP1224285A4 (fr) 27 proteines humaines secretees
EP1212342A4 (fr) 18 proteines secretees humaines
EP1226231A4 (fr) 19 proteines humaines secretees
EP1175438A4 (fr) Soixante-deux prot ines humaines s cr t es
EP1192278A4 (fr) 48 proteines secretees humaines
EP1192176A4 (fr) 49 proteines secretees humaines
EP1175439A4 (fr) 49 proteines humaines secretees
EP1165827A4 (fr) 45 proteines humaines secretees
EP1159284A4 (fr) 33 proteines humaines secretees
EP1189917A4 (fr) 48 proteines humaines secretees
EP1185543A4 (fr) 50 proteines humaines secretees
EP1224201A4 (fr) 32 proteines humaines secretees
EP1173477A4 (fr) 49 proteines humaines secretees
EP1203005A4 (fr) 25 proteines secretees humaines
EP1206573A4 (fr) 26 proteines humaines secretees
EP1169332A4 (fr) Proteines humaines secretees (49)
EP1171460A4 (fr) 48 proteines secretees humaines
EP1165602A4 (fr) 49 proteines secretees par un etre humain
EP1144614A4 (fr) Proteines humaines secretees (33)
EP1165828A4 (fr) 50 proteines humaines secretees
EP1228082A4 (fr) Proteines humaines secretees 29
EP1185285A4 (fr) 49 proteines secretees humaines

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011228

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07H 21/02 A, 7C 07H 21/04 B, 7C 12N 1/20 B, 7C 12N 15/00 B, 7C 12N 15/09 B, 7C 12N 15/63 B, 7C 12N 15/70 B, 7C 12N 15/74 B

A4 Supplementary search report drawn up and despatched

Effective date: 20030414

17Q First examination report despatched

Effective date: 20030702

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040513